Skip to main content
Skip to main content
CVET logo

Covetrus, Inc. (CVET)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Covetrus, Inc. (CVET) operates in the Healthcare sector, last quoted at $20.99 with a $0 market capitalization. Rated 45/100 (cautious) on growth potential, financial health, and momentum.

Last analyzed: 2026年2月8日
45/100 AI Score Vol 6M

Covetrus, Inc. (CVET) Healthcare & Pipeline Overview

CEOBenjamin Wolin
Employees4035
HeadquartersPortland, ME, US
IPO Year2019

Covetrus is a leading animal-health technology and services company, providing comprehensive solutions to veterinary practices worldwide. With a focus on technology-driven efficiency and a broad product portfolio, Covetrus empowers veterinary professionals to deliver superior care and enhance their business performance in the growing animal health market.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: 2026年2月8日

Investment Thesis

Covetrus presents a notable research candidate within the animal health sector, driven by the increasing demand for veterinary services and pet ownership globally. The company's comprehensive suite of products and technology solutions positions it as a key partner for veterinary practices. Key value drivers include expanding its proprietary product offerings, increasing adoption of its software solutions, and leveraging its distribution network to reach more customers. While financial data is limited due to its private status, Covetrus's focus on technology and value-added services should drive revenue growth and improved profitability. The company's commitment to supporting veterinary practices through innovative solutions makes it a strong contender in the evolving animal health landscape.

Based on FMP financials and quantitative analysis

Key Highlights

  • Covetrus operates as an animal-health technology and services company.
  • The company offers a wide range of animal-health consumable products, including pharmaceuticals, vaccines, and supplements.
  • Covetrus provides value-added solutions such as inventory management and e-commerce platforms.
  • The company offers practice management software and data-driven applications to enhance business health for veterinary practices.
  • Covetrus serves the companion-animal, equine, and large-animal markets across North America, Europe, and the Asia Pacific regions.

Competitors & Peers

Strengths

  • Comprehensive product and service offerings.
  • Established distribution network.
  • Proprietary and Covetrus branded products.
  • Technology-driven solutions for veterinary practices.

Weaknesses

  • Reliance on third-party suppliers.
  • Negative profit margin.
  • High beta indicates higher volatility.
  • Taken private, limiting investor access and transparency.

Catalysts

  • Expansion of proprietary product portfolio to increase margins.
  • Increased adoption of practice management software to drive recurring revenue.
  • Strategic partnerships to expand market reach and product offerings.

Risks

  • Economic downturn impacting pet owner spending on veterinary care.
  • Increased competition from established and emerging players in the animal health market.
  • Changes in animal health regulations affecting product approvals and distribution.
  • Reliance on third-party suppliers for key products.

Growth Opportunities

  • Expansion of Proprietary Product Portfolio: Covetrus has the opportunity to increase its profitability by developing and marketing its own branded products. The global market for animal health products is estimated to reach $50 billion by 2027. By focusing on innovative and high-margin products, Covetrus can differentiate itself from competitors and capture a larger share of this growing market. A strong pipeline of proprietary products will also enhance customer loyalty and create a more sustainable revenue stream.
  • Increased Adoption of Software Solutions: Covetrus offers a suite of practice management software and data-driven applications designed to improve efficiency and enhance business health for veterinary practices. The market for veterinary software is projected to reach $1 billion by 2028. By focusing on user-friendly design and seamless integration with existing systems, Covetrus can drive adoption of its software solutions and generate recurring revenue streams.
  • Leveraging Distribution Network: Covetrus has an established distribution network that reaches veterinary practices across North America, Europe, and the Asia Pacific. By optimizing its logistics and expanding its reach into underserved markets, Covetrus can increase its sales volume and market share. The company can also leverage its distribution network to introduce new products and services to its existing customer base.
  • Strategic Partnerships and Acquisitions: Covetrus can accelerate its growth by forming strategic partnerships with other companies in the animal health industry. These partnerships can provide access to new technologies, products, and markets. Covetrus can also pursue acquisitions of smaller companies to expand its product portfolio and geographic reach. Strategic partnerships and acquisitions can help Covetrus to strengthen its competitive position and drive long-term growth.
  • Focus on Value-Added Services: In addition to product distribution and software solutions, Covetrus offers a range of value-added services such as inventory management, e-commerce platforms, and continuing education. By expanding its offerings in these areas, Covetrus can strengthen its relationships with veterinary practices and generate additional revenue streams. A focus on providing comprehensive solutions will help Covetrus to differentiate itself from competitors and become a trusted partner for veterinary professionals.

Opportunities

  • Expansion into new geographic markets.
  • Development of new proprietary products and services.
  • Increased adoption of software solutions.
  • Strategic partnerships and acquisitions.

Threats

  • Competition from other distributors and technology providers.
  • Changes in animal health regulations.
  • Economic downturn affecting pet ownership and spending.
  • Disruptive technologies.

Competitive Advantages

  • Established distribution network across North America, Europe, and Asia Pacific.
  • Comprehensive suite of products and services for veterinary practices.
  • Proprietary and Covetrus branded products.
  • Practice management software and data-driven applications.

About CVET

Covetrus, Inc. was incorporated in 2018 and is headquartered in Portland, Maine. Though relatively young as a corporation, Covetrus was formed with the intent to revolutionize the animal health industry. The company operates as a global animal-health technology and services provider, offering a wide array of products and solutions to veterinary practices. These include animal-health consumable products, such as proprietary and Covetrus branded products, small and large equipment, laboratory products, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements. Beyond product distribution, Covetrus provides value-added solutions like inventory management, e-commerce platforms, and continuing education services. The company also offers practice management software, data-driven applications, and client communication tools designed to increase staff efficiency and improve business health for veterinary practitioners and animal-health clinics. Covetrus serves the companion-animal, equine, and large-animal markets across North America, Europe, and the Asia Pacific regions. As of October 13, 2022, Covetrus was taken private, marking a new chapter in its evolution.

What They Do

  • Distributes animal-health consumable products.
  • Offers proprietary and Covetrus branded products.
  • Provides small and large equipment for veterinary practices.
  • Distributes branded and generic pharmaceuticals and vaccines.
  • Offers practice management software and data-driven applications.
  • Provides value-added solutions like inventory management and e-commerce.
  • Offers continuing education services for veterinary practitioners.

Business Model

  • Sales of animal-health consumable products to veterinary practices.
  • Subscription fees for practice management software and data-driven applications.
  • Service fees for value-added solutions such as inventory management and e-commerce.
  • Distribution of finished goods pharmacy and specialty pharmaceutical compounding products.

Industry Context

The animal health industry is experiencing steady growth, driven by increasing pet ownership and rising expenditure on animal care. Technological advancements are playing a crucial role, with veterinary practices adopting digital solutions to improve efficiency and enhance patient care. Covetrus operates within this dynamic landscape, competing with other distributors and technology providers. The industry is characterized by consolidation, with larger players acquiring smaller companies to expand their product portfolios and geographic reach. Covetrus's focus on technology and value-added services positions it favorably to capitalize on these trends and gain market share.

Key Customers

  • Veterinary practices and clinics.
  • Companion-animal market.
  • Equine market.
  • Large-animal market.
AI Confidence: 71% Updated: 2026年2月8日

Financials

Chart & Info

Covetrus, Inc. (CVET) stock price: $20.99 (+0.00, +0.00%)

Latest News

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CVET.

Price Targets

Wall Street price target analysis for CVET.

MoonshotScore

45/100

What does this score mean?

The MoonshotScore rates CVET's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

CVET Healthcare Stock FAQ

What are the key factors to evaluate for CVET?

Covetrus, Inc. (CVET) currently holds an AI score of 45/100, indicating low score. Key strength: Comprehensive product and service offerings. Primary risk to monitor: Economic downturn impacting pet owner spending on veterinary care. This is not financial advice.

How frequently does CVET data refresh on this page?

CVET prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven CVET's recent stock price performance?

Recent price movement in Covetrus, Inc. (CVET) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Comprehensive product and service offerings. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider CVET overvalued or undervalued right now?

Determining whether Covetrus, Inc. (CVET) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying CVET?

Before investing in Covetrus, Inc. (CVET), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding CVET to a portfolio?

Potential reasons to consider Covetrus, Inc. (CVET) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Comprehensive product and service offerings. Additionally: Established distribution network. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.

Can I buy fractional shares of CVET?

Yes, most major brokerages offer fractional shares of Covetrus, Inc. (CVET) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track CVET's earnings and financial reports?

Covetrus, Inc. (CVET) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for CVET earnings announcements is recommended.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • Financial data is limited due to the company being private.
  • Stock data pending update.
Data Sources

Popular Stocks